Ads
related to: clinical trials- Find a Location
Get Directions To The James
Locations in Central Ohio
- Find A Doctor
Browse The James Top Doctor By
Specialty, Cancer Type or Name
- Follow the Blog
Get The Latest News
And Updates from The James
- Treat Cancer & Diagnose
The James is Home to
World-Renowned Cancer Experts
- New Diagnostic Center
Same or Next Day Access to
Cancer Diagnostic Experts
- Immunotherapy Management
Proactively mitigating side effects
Well-being beyond cancer treatment
- Find a Location
Search results
Earnings call: NRx Pharmaceuticals outlines strategic growth and clinical advances By Investing.com
Investing.com· 2 hours agoNRx Pharmaceuticals (NRXP) reported a reduction in net loss and advancements in their clinical...
What the results of Wegovy’s longest clinical trial yet show about weight loss, side effects and...
CNN via Yahoo News· 2 days agoNew analyses of the longest clinical trial yet of the weight-loss drug Wegovy are shedding light on...
Earnings call: BioCardia optimistic amid clinical trial progress and Japan strategy By Investing.com
Investing.com· 57 minutes agoBioCardia, Inc. (NASDAQ:BCDA) has reported a mixed financial performance in Q1 2024, alongside...
Veru Inc. enlists top obesity expert for clinical trial By Investing.com
Investing.com· 49 minutes agoInc. (NASDAQ: NASDAQ:VERU), a biopharmaceutical company, has announced the appointment of Dr. Steven...
Medidata expands clinical trial software partnership with Worldwide Clinical Trials
Clinical Trials Arena via Yahoo Finance· 7 hours agoThe software solutions aim to provide a more comprehensive view of patients by incorporating data...
Earnings call: BioAtla reports promising data in cancer drug trials By Investing.com
Investing.com· 55 minutes agoBioAtla, a biotechnology company, has announced its first-quarter financial results and provided a...
OCT Europe: Unless everyone is benefiting, what is the point?
Clinical Trials Arena via Yahoo Finance· 6 hours agoPatient-centricity has been a buzzword in the clinical trial industry for the past few years with...
Ocugen completes second cohort dosing in Stargardt trial By Investing.com
Investing.com· 47 minutes agoOcugen, Inc. (NASDAQ: NASDAQ:OCGN), a biotechnology company, announced today the completion of...
Acurx gears up for Phase 3 trials of CDI antibiotic candidate By Investing.com
Investing.com· 1 hour agoAcurx Pharmaceuticals, Inc. (NASDAQ: ACXP), a biopharmaceutical company specializing in the...
Earnings call: Belite Bio highlights progress in key drug trials, Q1 financials By Investing.com
Investing.com· 1 hour agoBelite Bio, a biopharmaceutical company focused on developing treatments for ocular diseases, has...